Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting.
about
TGF-β cascade regulation by PPP1 and its interactors -impact on prostate cancer development and therapymiR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymesEndothelial Caveolin-1 regulates the radiation response of epithelial prostate tumors.Reduced expression of AMPK-β1 during tumor progression enhances the oncogenic capacity of advanced ovarian cancerLigand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.Apoptosis by dietary agents for prevention and treatment of prostate cancerThe effects of self-assembling peptide RADA16 hydrogel on malignant phenotype of human hepatocellular carcinoma cell.Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate CancerChemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care.Role of p38 MAP Kinase Signal Transduction in Solid TumorsProstate cancer: the need for biomarkers and new therapeutic targets.The role of caveolin-1 in prostate cancer: clinical implications.Autophagy in prostate cancer and androgen suppression therapy.The Role of Testosterone in the Treatment of Castration-Resistant Prostate Cancer.Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo.PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation.A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells.RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicityEnterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells.Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?Periacinar retraction clefting in nonneoplastic and neoplastic prostatic glands: artifact or molecular involvement.Angiogenic and tissue remodeling factors in the prostate of elderly rats submitted to hormonal replacement.Disorders related with ageing in the gerbil female prostate (Skene's paraurethral glands).Reactive stroma in the prostate during late life: The role of microvasculature and antiangiogenic therapy influences.Antiangiogenic therapy effects on age-associated matrix metalloproteinase-9 (MMP-9) and insulin-like growth factor receptor-1 (IGFR-1) responses: a comparative study of prostate disorders in aged and TRAMP mice.The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression
P2860
Q26862838-860368AC-1513-4F44-8BFB-F8422A8E3F6BQ28476613-F037E9F9-DB66-4EE4-ABB4-7418C566518CQ30652492-19BA7E00-F900-44BC-B74E-683AA6E575D7Q33590428-73B135AF-B88E-4400-BC53-9ACFED6286B6Q34496697-A8BCD2B9-4B6A-4CA8-AF53-1AF6C8BDEAD5Q34614042-B11D5BDB-674A-4F9E-ABCF-A5B1A65C6344Q36317361-AD4BDA8E-E64D-4F22-BB69-E9F88BF0AAEEQ36699939-F5A70F86-B76E-44B9-9DC7-614D0862F2E5Q37234005-B526FAE8-8437-453C-8589-C64C9910CDC4Q37392558-F56B7360-7F41-42D1-9A57-4C3E82E75B03Q37476043-FAF86339-0216-4BE2-BE05-442E54D33E7DQ37542947-EC4722CE-1432-4828-BFE4-1DC25E6E6928Q38112596-FCAC7CE3-B038-4A91-A1CF-9886D446C631Q38810776-70BB615B-902F-4663-BCDD-29912916B7E8Q38829200-679D90C4-92E4-4F71-A0C7-6DAC00419F63Q38909525-4ECD55DB-ED21-4F4F-ACFF-3D06D1BD3B5AQ39192814-DD7322A6-197B-4C13-88CB-D3FBD00F73B9Q39718113-4243EEA9-D4B7-4EDA-BE79-CBCE83167576Q39863204-37499C24-D3A1-451E-AF6D-1E63D1C3A4BBQ39884727-AE8D04D8-59D6-4B5B-B5AC-F784711777B9Q40707324-C2584ACC-4844-4A7B-937D-88943487F323Q42494241-50048F22-29A7-4C69-AC7E-38AF0CB06894Q44660978-D51F22DD-A88C-4D3A-B3EE-40B2497EAF58Q51594473-FA88A367-944A-4975-A694-A780414D3EA7Q53421985-8405923E-BE1D-4D2E-B2A1-D5126FD65E9BQ54375534-F408A7DB-88AC-449A-AC00-9EB891E81CA4Q55425609-62437078-7F12-4C6D-B999-8421D6570FDCQ57142667-972C9276-C1A0-4551-A9E7-CCBEC7B33371
P2860
Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Growth factor signalling in pr ...... ent and therapeutic targeting.
@ast
Growth factor signalling in pr ...... ent and therapeutic targeting.
@en
type
label
Growth factor signalling in pr ...... ent and therapeutic targeting.
@ast
Growth factor signalling in pr ...... ent and therapeutic targeting.
@en
prefLabel
Growth factor signalling in pr ...... ent and therapeutic targeting.
@ast
Growth factor signalling in pr ...... ent and therapeutic targeting.
@en
P2860
P356
P1476
Growth factor signalling in pr ...... ent and therapeutic targeting.
@en
P2093
Arich Ryan Reynolds
Natasha Kyprianou
P2860
P304
P356
10.1038/SJ.BJP.0706635
P407
P478
147 Suppl 2
P577
2006-02-01T00:00:00Z